June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Assessment of eye pain symptoms among pediatric students during the COVID-19 pandemic
Author Affiliations & Notes
  • Jason Dossantos
    The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Julie Thomasian
    The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, United States
  • Monica Maria Manrique
    Ophthalmology, Children's National Hospital, Washington, District of Columbia, United States
  • Isabelle Dortonne
    Ophthalmology, Children's National Hospital, Washington, District of Columbia, United States
  • Richard Birdsong
    Ophthalmology, Children's National Hospital, Washington, District of Columbia, United States
  • Footnotes
    Commercial Relationships   Jason Dossantos None; Julie Thomasian None; Monica Manrique None; Isabelle Dortonne None; Richard Birdsong None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3272 – A0324. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jason Dossantos, Julie Thomasian, Monica Maria Manrique, Isabelle Dortonne, Richard Birdsong; Assessment of eye pain symptoms among pediatric students during the COVID-19 pandemic. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3272 – A0324.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Computer Vision Syndrome (CVS) is a form of asthenopia that manifests with symptoms such as eye pain/discomfort, headache, and blurred vision, among others. Early identification of CVS is especially relevant during the COVID-19 pandemic, which has led to an increase in virtual schooling and digital screen time among children worldwide. This study seeks to evaluate differences in etiologies of eye pain, treatment recommendations, and the relationship between refractive errors and eye pain in the pediatric population before and during the COVID-19 pandemic.

Methods : After IRB approval, we retrospectively reviewed the records of patients who visited our tertiary care institution between 2018 and 2021 with a chief complaint of eye pain, determined by the encounter’s primary ICD-10 code. Patients who visited before 03/11/2020, when the WHO declared COVID-19 a pandemic, were classified as the pre-pandemic group (PPG), while patients who consulted after this date were classified as the during-pandemic group (DPG). Demographics, symptoms, refractive error, treatment, and schooling method were recorded as covariates and analyzed using a Chi-square and Fisher’s exact test.

Results : 38 patients were included in the study (21 PPG; 17 DPG). The mean age was 10.1 ± 3.2 years, and the majority were African American (44.7%). Virtual school attendance for the PPG and DPG was 4.8% and 58.8%, respectively (P<0.05) (Table 1). There was a higher prevalence of reported blurry vision, headaches, eye redness, eye swelling, and rubbing among DPG patients (Table 1). Counseling on screen time minimization was more likely to be documented in the DPG (Table 2). A greater proportion of patients were prescribed new glasses in the DPG though there was no significant relationship between eye pain and refractive error or anisometropia in either group (P>0.05).

Conclusions : The increased prevalence of CVS symptoms in the DPG suggests an association between virtual schooling and CVS in children. There is a role for ophthalmologists to improve rates of counseling for the prevention of eye pain-related symptomatology with digital device usage. Further studies will survey parents to assess their awareness of conservative treatments for eye pain such as artificial tears and decreased screen time.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

Table 1. Differences in virtual schooling and symptoms between groups

Table 1. Differences in virtual schooling and symptoms between groups

 

Table 2. Differences in treatment between groups

Table 2. Differences in treatment between groups

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×